Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed director
Quarterly results
CC transcript
|
|
ENDOLOGIX INC (ELGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/24/2020 |
8-K
| Quarterly results |
| 04/01/2019 |
8-K
| Credit agreement amendment|
Docs:
|
"Form of Pre-Paid Warrant to Purchase Common Stock",
"Form of Amended and Restated Initial (2017) Warrant",
"Form of Amended and Restated Additional (2018) Warrant",
"Form of First Out Waterfall Note",
"Form of Indenture in respect of 5.00% Mandatory Convertible Senior Notes due 2024",
"Form of 5.00% Mandatory Convertible Senior Note due 2024",
"Form of Indenture in respect of 5.00% Voluntary Convertible Senior Notes due 2024",
"Form of 5.00% Voluntary Convertible Senior Note due 2024",
"Opinion of DLA Piper LLP (US)",
"Purchase Agreement, among Endologix, Inc. and the investors named on Schedule I thereto" |
|
| 12/06/2013 |
8-K
| Credit agreement amendment|
Docs:
|
"Underwriting Agreement, by and between Endologix, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the several Underwriters",
"Base Capped Call Confirmation, between Endologix, Inc. and Bank of America, N.A",
"Additional Capped Call Confirmation, between Endologix, Inc. and Bank of America, N.A",
"Seventh Amendment to Credit Agreement, by and among Wells Fargo Bank, National Association, Endologix, Inc., and Nellix, Inc",
"ENDOLOGIX ANNOUNCES OFFERING OF $75 MILLION OF CONVERTIBLE NOTES",
"ENDOLOGIX ANNOUNCES PRICING OF $75 MILLION OF CONVERTIBLE NOTES" |
|
| 02/24/2012 |
8-K
| Form 8-K - Current report |
|
|